Filtrer vos résultats
- 2
- 1
- 3
- 3
- 1
- 1
- 1
- 3
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 3
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
|
FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown originDigestive and Liver Disease, 2021, 53 (7), pp.824-829. ⟨10.1016/j.dld.2021.04.016⟩
Article dans une revue
hal-03333521v1
|
||
|
Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)Digestive and Liver Disease, 2018, 50 (1), pp.15 - 19. ⟨10.1016/j.dld.2017.09.123⟩
Article dans une revue
hal-01708040v1
|
||
Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD‐NADEGE cohort study of 347 patientsInternational Journal of Cancer, 2020, ⟨10.1002/ijc.32860⟩
Article dans une revue
hal-02532893v1
|